Buy the stocks of these companies helping fuel the ‘AI gold rush,’ analyst says
With demand for the use of artificial intelligence expected to continue to surge, Oppenheimer analyst Edward Yang recommended investors buy the stocks of a couple...
The Curious Inability To Spend Money On Yourself
Recently, I hit a major milestone in my journey to overcome what I like to call “frugality disease.” I spent $160 for an hour of...
Merrill Lynch and Harvest Volatility paying $9.3 million in fines for derivatives trades
Fines follow probe of Harvest’s Collateral Yield Enhancement Strategy (CYES).
New-home sales retreat after big jump in prior month
New-home sales fell in August, but still beat estimates.
Most workers still struggle to invest in their retirement. Here’s how cheap robo advisers can help.
Nearly 80% of workers say they don’t know much about their finances.
Nvidia investors just got a $1 trillion reason to be even more bullish
Nvidia’s stock is gaining as a new report projecting big growth in the AI market offers some relief to investors worried about the pace of...
It’s a ‘golden age’ of fixed income, says bond-market goliath
Stocks can still ‘do well,’ but the compensation for taking equity risk is near the lowest in 20 years, BlackRock CIO says
SEC charges Merrill Lynch, Harvest Volatility Management for ignoring client investment limits
They will pay a combined $9.3 million after the Securities and Exchange Commission charged them for exceeding clients' investment limits over a two-year period.
Novo Nordisk’s diabetes drug Ozempic may lower the risk of opioid overdoses, study says
The results suggest Ozempic could potentially become a new alternative treatment for opioid use disorder, which could help address the ongoing opioid epidemic.